Comments Regarding Identification, Assessment, and Control of Nitrosamine Drug Substance-Related Impurities in Human Drug Products Share page: Docket Number: FDA-2023-N-1585-0001 Download Document Issues: OTC Medicines Other Issues Quality Related Posts Press Releases and Statements CHPA Recognizes International Self-Care Day, Underscores Value of Consumer Healthcare Products Jul 24, 2024 Public Policy & Regulatory Press Releases and Statements Strengthening the Self-Care Community: CHPA Welcomes 15 New Members & Celebrates Longtime Partnerships Jul 22, 2024